A.G.P./Alliance Global Partners has hired James Molloy as Managing Director and Biotechnology & Specialty Pharmaceuticals Equity Research Analyst.

Jim provides coverage of companies in several therapeutic categories in the biotechnology and pharmaceuticals sector, with a focus on immuno-oncology, central nervous system, cardiovascular, and anti-infective disorders. Prior to A.G.P., Jim was a Managing Director, Biotechnology and Specialty Pharmaceuticals Equity Research Analyst at Laidlaw Capital Markets, Janney Montgomery Scott, Senior Analyst at ThinkEquity Partners, and a Vice President of Equity Research at Oppenheimer and Company.

Jim has almost two decades of experience as a Senior Analyst covering both the mid-capitalization and emerging biotechnology and pharmaceutical sectors. He began his career as one of the first three analysts at Leerink Partners in Boston. He earned an MBA from the FW Olin Graduate School of Business at Babson College, and a BA from the University of Colorado, Boulder.

A.G.P. Executive Chairman Phil Michals noted: “We are very fortunate to have Jim join our team. He really understands this highly complex and constantly evolving space, and he has great relationships in the industry.”

ABOUT A.G.P.
A.G.P./Alliance Global Partners is a full-service, national investment firm and SEC registered broker-dealer for the past 37 years. A.G.P. has a global reach with 10 locations across the United States. A.G.P. provides wealth management, institutional and corporate services with access to a wide array of products and offerings, including: Investment advisory; fixed income; retail services and insurance; equity capital markets; debt capital markets; M&A; and sales and trading. A.G.P. also offers comprehensive sector-based research services. For more information, please go to: www.allianceg.com.

This communication is intended only for Institutional Investors and should not be made available to or relied upon or acted upon by Retail Investors. It may not be reproduced, redistributed, or forwarded to any other person, except to the client’s professional advisor, and may not be published in whole or in part for any purpose without obtaining prior express written consent of A.G.P. This material is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation of any security or investment strategy. Past performance does not indicate future results; investing always involves risk; and no investment is protected against loss. Consider your investment objectives carefully before investing.